JP Morgan Chase’s AMAG Pharmaceuticals AMAG Stock Holding History

JP Morgan Chase’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-7,381,580	Closed	-$166M	–	5348
2017 Q1	$166M	Hold	7,381,580	–	–	0.04%	456
2016 Q4	$257M	Sell	7,381,580 -72,490	-1%	-$2.17M	0.06%	320
2016 Q3	$183M	Buy	7,454,070 +72,490	+1%	+$1.81M	0.05%	389
2016 Q2	$177M	Hold	7,381,580	–	–	0.04%	402
2016 Q1	$173M	Buy	+7,381,580	New	+$175M	0.04%	408

JP Morgan Chase's AMAG Position: Q4 2020 in Review

JP Morgan Chase sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 82,705 shares — an estimated $767K sold.

JP Morgan Chase first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $29.7M in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

JP Morgan Chase reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
JP Morgan Chase sold 82,705 AMAG Pharmaceuticals shares in Q4 2020, an estimated $767K.
JP Morgan Chase first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
JP Morgan Chase's AMAG Pharmaceuticals position peaked at $29.7M in Q4 2016.
1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.